FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Carbidopa and Levodopa Extended Release Tablets
Status: Resolved
»Duration of Shortage: 09/27/2017 - 07/12/2019
»Therapeutic Categories: Neurology

Expand all

Accord Healthcare Inc. (Revised 07/12/2019)

Company Contact Information:
866-941-7875, Option 1 or 3

Presentation
  • CARBIDOPA & LEVODOPA ER TABLETS 50MG/200MG 100CT; (NDC 1672907901)
  • CARBIDOPA & LEVODOPA ER TABLETS 50MG/200MG 1000CT; (NDC 1672907917)
  • CARBIDOPA & LEVODOPA ER TABLETS 25MG/100MG 100CT; (NDC 1672907801)
  • CARBIDOPA & LEVODOPA ER TABLETS 25MG/100MG 1000CT; (NDC 1672907817)
Note:
  • Stocks available to support current customer demand

Mylan Pharmaceuticals Inc. (Revised 07/12/2019)

Company Contact Information:
800-796-9526

Presentation
  • Carbidopa and Levodopa Extended Release Tablets, 25/100 mg (NDC 0378-0088-01)
  • Carbidopa and Levodopa Extended Release Tablets, 50/200 mg (NDC 0378-0094-01)
Note:
  • N/A

Sun Pharmaceutical Industries Inc. (Revised 07/12/2019)

Company Contact Information:
800-810-4555

Presentation
  • Carbidopa and Levodopa Extended Release Tablets 25-100 mg (NDC 62756-461-88 )
  • Carbidopa and Levodopa Extended Release Tablets 50-200 (NDC 62756-457-88)
Note:
  • Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English